Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / C••••••• T••••• L••••••••• S•••••••

T••••••• S••••• Capital Partners Portfolio Company B••••• Acquires C••••••• T••••• L••••••••• S•••••••

Add-on acquisitionclosedadd-onannounced Oct 8, 2018closed Oct 8, 2018Fact
What happened
Target
C••••••• T••••• L••••••••• S•••••••
Platform
B•••••add-on basis: T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company B•••••, a leading global provider of research models and value-added research services for drug discovery and development, has acquired C••••••• T••••• L••••••••• S••••••• (CTLS).
Control
Control
Share acquired
unknown
Industry
healthcare / clinic, laborator
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
3 named
Buy side
  • B•••••Platformconfirmed
    “T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company B•••••, a leading global provider of research models and value-added research services for drug discovery and development, has acquired C••••••• T••••• L••••••••• S••••••• (C”
  • T••••••• S••••• C•••••• M•••••• L••Sponsorconfirmed
    “T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company B•••••, a leading global provider of research models and value-added research services for drug discovery and development, has acquired C••••••• T••••• L••••••••• S••••••• (C”
Side not stated
  • C••••••• T••••• L••••••••• S•••••••Targetconfirmed
    “T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company B•••••, a leading global provider of research models and value-added research services for drug discovery and development, has acquired C••••••• T••••• L••••••••• S••••••• (C”
Evidence
“T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company B•••••, a leading global provider of research models and value-added research services for drug discovery and development, has acquired C••••••• T••••• L••••••••• S••••••• (CTLS).”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
T••••••• S••••• Capital Partners Portfolio Company B••••• Acquires C••••••• T••••• L•••••• | Private Equity Intelligence | DFX